Finance

Lists
Why is AREC up 3.03%?
Dive Deeper
AREC:LON
Arecor Therapeutics PLC
GBX 85.00
+3.03%
(+2.50) 1D
Nov 2, 4:07:07 PM UTC  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for AREC...
Mkt. cap
37.37M
Avg. vol.
27.72K
Volume
0.00
52-wk high
GBX 95.00
52-wk low
GBX 55.27
EPS
-GBX 0.00
Shares outstanding
45.30M
No. of employees
33
Mkt. cap
37.37M
Avg. vol.
27.72K
Volume
0.00
52-wk high
GBX 95.00
52-wk low
GBX 55.27
EPS
-GBX 0.00
Shares outstanding
45.30M
No. of employees
33
News stories
From web sources and news partners
About Arecor Therapeutics PLC
CEO-
Employees33
Founded2007
Headquarters-
SectorBiotechnology
Websitearecor.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
97.00K
97.00K
Cost of goods sold
-
-
78.50K
78.50K
Cost of revenue
-
-
78.50K
78.50K
Research and development expenses
-
-
932.50K
932.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
745.50K
745.50K
Operating expense
-
-
1.60M
1.60M
Total operating expenses
-
-
1.68M
1.68M
Operating income
-
-
-1.58M
-1.58M
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-1.54M
-1.54M
EBT excluding unusual items
-
-
-1.54M
-1.54M
Income tax expense
-
-
-35.00K
-35.00K
Effective tax rate
-
-
2.27%
2.27%
Other operating expenses
-
-
-78.50K
-78.50K
Net income
-
-
-1.49M
-1.49M
Net profit margin
-
-
-1,537.11%
-1,537.11%
Earnings per share
-
-
-
-
Interest and investment income
-
-
39.00K
39.00K
Interest expense
-
-
-1.50K
-1.50K
Net interest expenses
-
-
37.50K
37.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-1.53M
-1.53M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps